Clinical Challenges and Engineering Solutions in Cancer Immunotherapy: What Do We Need Now?

PEGS Europe Virtual – November 12, 2020
Programs: Keynote Presentation in Novel Targets and Emerging Therapeutic Areas & in Engineering Bispecific Antibodies

Daniel S. Chen, MD, PhD, Chief Medical Officer
IGM Biosciences, Inc., 325 E Middlefield Road, Mountain View, CA 94043

PEGS EU 2020 Keynote DSChen

Posted in publications.